Fludarabine and Acute Tumor Lysis in Chronic Lymphocytic Leukemia

Authors:
  • JFJ N Frame
    J N Frame
  • WDW L Dahut
    W L Dahut
  • SCS Crowley
    S Crowley

Abstract
Fludarabine, the 2-fluoro,5′-phosphate derivative of vidarabine, is a rare cause of acute tumor lysis syndrome in chronic lymphocytic leukemia.1 This complication has been reported to occur only after the initial treatment cycle of fludarabine. We describe a patient with chronic lymphocytic leukemia in whom the syndrome of acute tumor lysis leading to acute renal failure unexpectedly developed after the third cycle of fludarabine therapy.